Home › Lymphoma › District of Columbia
Lymphoma clinical trials in District of Columbia
7 studies for Lymphoma are looking for participants at sites in District of Columbia.
Cities in District of Columbia
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
- Children's National Medical Center, Washington D.C.
RecruitingPhase 1/2
12 Months – 21 Years · All sexes · Updated Sep 11, 2026 · NCT04870944A Study to Evaluate Glofitamab as a Single Agent vs. Investigator's Choice in Participants With Relapsed/Refractory Mantle Cell Lymphoma
- Georgetown University, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06084936Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Medstar Georgetown University Hospital, Washington D.C.
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Aug 25, 2026 · NCT05826535A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma
- Georgetown University (Data Collection Only), Washington D.C.
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 10, 2026 · NCT05389293A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- MedStar Georgetown University Hospital, Washington D.C.
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Aug 4, 2026 · NCT07188558Mosaic Trial for Stem Cell Transplant Recipients
- Georgetown University School of Medicine, Washington D.C.
Recruiting
Ages 18 and older · All sexes · Updated Aug 3, 2026 · NCT06960993Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers
- George Washington University, Washington D.C.
RecruitingObservational study
Ages 18 and older · All sexes · Updated Jun 1, 2026 · NCT05663502From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.